Di-and tetranuclear heterometallic Cu~Ⅱ-Ln~Ⅲ complexes (Ln=Gd and Dy): Synthesis, structure and magn

来源 :中国科学:化学 | 被引量 : 0次 | 上传用户:xyz880330
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Four 3d-4f heterometallic complexes, [Cu~ⅡLn~Ⅲ(bpt)2(NO3)3(MeOH)] (Ln = Gd, 1; Dy, 2; bptH = 3,5- bis(pyrid-2-yl)-1,2,4- triazole), [Cu~Ⅱ2Ln~Ⅲ2(μ-OH)2(bpt)4Cl4 (H2O)2]·6H2O (Ln = Gd, 3; Dy, 4), have been synthesized under solvothermal conditions. X-ray structural analyses reveal that 1 and 2 are isostructural while 3 and 4 are isostructural. In each complex, the copper and gadolinium or dysprosium ions are linked by two triazolate bridges and form a Cu~Ⅱ-Ln~Ⅲ dinuclear unit. The intramolecular Cu-Ln distances are 4.542, 4.525, 4.545 and 4.538  for 1, 2, 3 and 4, respectively. Two dinuclear CuLn units are bridged by two OH- groups into the zig-zag tetranuclear {Cu~Ⅱ2Ln~Ⅲ2} structures with the Ln(Ⅲ)…Ln(Ⅲ) distances of 3.742 and 3.684  for 3 and 4, respectively. Magnetic studies show that the antiferromagnetic Cu~Ⅱ-Ln~Ⅲ interactions occur in 1 (JCuGd = -0.21 cm-1) and 2. The antiferromagnetic interaction occurs in complex 3 with JCuGd = -0.82 cm-1 and JGdGd = -0.065 cm-1, while dominant ferromagnetic interaction occurs in complex 4. Four 3d-4f heterometallic complexes [Cu ~ IILn ~ III (bpt) 2 (NO3) 3 (MeOH)] (Ln = Gd, 1; Dy, 2; bptH = -1,2,4-triazole, and [Cu ~ Ⅱ2Ln ~ Ⅲ2 (μ-OH) 2 (bpt) 4Cl4 (H2O) 2] · 6H2O (Ln = Gd, 3; Dy, 4) have been synthesized under solvothermal conditions. X-ray structural analyzes reveal that 1 and 2 are isostructural while 3 and 4 are isostructural. In each complex, the copper and gadolinium or dysprosium ions are linked by two triazolate bridges and form a Cu ~ II-Ln ~ III dinuclear unit . The intramolecular Cu-Ln distances are 4.542, 4.525, 4.545 and 4.538  for 1, 2, 3 and 4, respectively. Two dinuclear CuLn units are bridged by two OH- groups into the zig-zag tetranuclear {Cu ~ Ⅱ 2Ln ~ Ⅲ 2 } structures with the Ln (Ⅲ) ... Ln (Ⅲ) distances of 3.742 and 3.684  for 3 and 4, respectively. Magnetic studies show that the antiferromagnetic Cu ~ Ⅱ-Ln ~ Ⅲ interactions occur in 1 (JCuGd = -0.21 cm- 1) and 2. The antiferromagnetic interaction occurs in complex 3 with JCuGd = -0.82 cm-1 and JGd Gd = -0.065 cm-1, while dominant ferromagnetic interaction occurs in complex 4.
其他文献
目的:对三七药性菌质中正丁醇部位的化学成分进行研究。方法:采用系统溶剂萃取、D101大孔吸附树脂、硅胶柱色谱、开放式ODS柱色谱、半制备液相等方法进行分离纯化,通过化学性
糖尿病足(Diabetic foot, DF)是糖尿病(DM)四种大血管合并症(高血压、DF、缺血性心脏病、脑血管病)之一。最早由Oakeg于1956年提出,1972年Catteral明确定义为DF是因神经病变
目的优选心神宁片的最优提取工艺条件。方法以干膏率及栀子苷、斯皮诺素的转移率为评价指标,以PlackettBurnman设计联合Box-Behnken设计-效应面法对心神宁片的提取工艺进行考
优生、优育、优教 ,生育、养育、教育 ,胎教、家教、社教等 ,是相关密切、相互促进的既要面向基层又需走向世界 ;换句话说 ,必需做好横向综合、纵向随访的时时日日严密求真务
一、遗传病与肿瘤基因治疗 基因治疗的设想最初源于遗传病的根治,早期的探索也是从遗传病开始的。随着基因治疗的发展和人们对疾病发病机制认识的深入,基因治疗的研究对象也
伏立康唑(voriconazole)是由美国辉瑞公司(Pifzer.Inc)研制开发的广谱抗真菌药。商品名为Vfend,于2006年10月获美国FDA批准上市。伏立康唑的化学名称:(2R,3S)-2-(2,4-二氟苯
他巴唑(MMI)是甲状腺功能亢进症(甲亢)内科治疗的首选药物,在为期1年半的疗程中可分为:初治、减药及维持量3个阶段。由于前两阶段用药量较大,对其每日总剂量的分配有不同主张和服法。有人[1]依他巴唑半寿期约6小时主张采用每6小时1次(Q6h)或每8小时1次(Q8h)的分服法;但该服法必有1次在夜间服用,有碍患者睡眠。据此多提倡免去夜间服用,改用白昼3次分服法(Tid),临床证明其疗效与Q6h或Q8
患者女,68岁,病期10年。腹部、腰背部大小不等的环状、半环状红斑,暗紫红色,环的边缘较宽,浸润明显,上附鳞屑,伴有明显瘙痒,组织病理诊断蕈样肉芽肿。用雷公藤合剂口服及外用氮芥生理盐水
目的:建立寒湿痹颗粒的质量标准。方法:采用薄层色谱法对处方中麻黄,甘草,桂枝,黄芪进行定性鉴别;采用高效液相色谱法对马兜铃酸A进行限量检查;采用高效液相色谱法测定芍药苷
笔者在临床治疗系统性红斑狼疮(SLE)时以中医辨证为基础,并根据病情分别加用大、中、小三种剂量甲基强的松龙(以下简称甲强龙)治疗,收到较好疗效。在充分发挥中医药特长,合